Should You Avoid Merge Healthcare Inc. (MRGE)?
To many of your peers, hedge funds are seen as useless, old investment vehicles of a period lost to current times.
Posts Tagged ‘James E. Flynn’
Hedge Funds Are Selling eHealth, Inc. (EHTH)
If you were to ask many investors, hedge funds are perceived as overrated, old investment vehicles of a period lost to current times.
Hedge Funds Aren’t Crazy About Vocera Communications Inc (VCRA) Anymore
In today’s marketplace, there are a multitude of gauges shareholders can use to monitor their holdings.
This Metric Says You Are Smart to Buy Air Methods Corp (AIRM)
If you were to ask many of your peers, hedge funds are perceived as delayed, outdated investment vehicles of an era lost to time.
Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
Edwards Lifesciences Corp (EW): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
To the average investor, there are a multitude of methods shareholders can use to monitor publicly traded companies.
Is XenoPort, Inc. (XNPT) Going to Burn These Hedge Funds?
At the moment, there are plenty of metrics market participants can use to monitor the equity markets.
Hedge Funds Are Dumping HeartWare International Inc (HTWR)
In the 21st century investor’s toolkit, there are plenty of metrics investors can use to monitor publicly traded companies.
Depomed Inc (DEPO): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
In the eyes of many market players, hedge funds are viewed as delayed, outdated financial vehicles of an era lost to time.
This Metric Says You Are Smart to Buy Sagent Pharmaceuticals Inc (SGNT)
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age.
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most innovative are hedge fund and insider trading sentiment.
Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
NxStage Medical, Inc. (NXTM): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
To many of your peers, hedge funds are perceived as overrated, old investment tools of a period lost to current times.
Here is What Hedge Funds Think About NuVasive, Inc. (NUVA)
To many of your fellow readers, hedge funds are viewed as delayed, outdated investment tools of a forgotten age.
Should You Avoid Molina Healthcare, Inc. (MOH)?
To the average investor, there are dozens of methods shareholders can use to analyze publicly traded companies.
Auxilium Pharmaceuticals, Inc. (AUXL): Are Hedge Funds Right About This Stock?
To many of your fellow readers, hedge funds are assumed to be useless, old investment vehicles of a period lost to current times.
What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
Hedge Funds Are Crazy About Catamaran Corp (USA) (CTRX)
Now, according to many market players, hedge funds are viewed as overrated, outdated investment vehicles of a forgotten age.
Is Amedisys Inc (AMED) Going to Burn These Hedge Funds?
In the eyes of many investors, hedge funds are seen as bloated, outdated financial vehicles of a period lost to current times.
St. Jude Medical, Inc. (STJ): Are Hedge Funds Right About This Stock?
In the eyes of many investors, hedge funds are perceived as overrated, old financial vehicles of a forgotten age.
Hologic, Inc. (HOLX): Are Hedge Funds Right About This Stock?
In the 21st century investor’s toolkit, there are many indicators market participants can use to watch stocks.
Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time.
Hedge Funds Aren’t Crazy About Amarin Corporation plc (ADR) (AMRN) Anymore
In the financial world, there are many metrics shareholders can use to track their holdings. A duo of the most innovative are hedge fund and insider trading movement.
Hedge Funds Are Selling Arena Pharmaceuticals, Inc. (ARNA)
Now, according to many market players, hedge funds are viewed as delayed, outdated financial tools of an era lost to time.
Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
What’s a Smart Cytokinetics, Inc. (CYTK) Investor To Do?
In the eyes of many of your peers, hedge funds are seen as useless, old investment tools of a forgotten age.
Why Does Polaris Capital Love Teva Pharmaceutical Industries Ltd (ADR) (TEVA) & Infosys Ltd ADR (INFY)?
Bernard Horn, the manager of Polaris Capital Management, is a former employee of MDT Advisers.
Arena Pharmaceuticals, Inc. (ARNA): What Do The Smartest Investors Think?
In the financial world, there are tons of indicators investors can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Pernix Therapeutics Holdings Inc (PTX): Are Hedge Funds Right About This Stock?
In the financial world, there are plenty of gauges market participants can use to track their holdings.
Alphatec Holdings Inc (ATEC): Insiders Are Buying, Should You?
Alphatec Holdings Inc (NASDAQ:ATEC) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
Arena Pharmaceuticals, Inc. (ARNA): The Short Data You Need To See
Nowadays, there are a multitude of indicators for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) traders to pay attention to, but it's smart to take note of a stock's shorts.
Cardiovascular Systems Inc (CSII): Are Hedge Funds Right About This Stock?
Cardiovascular Systems Inc (NASDAQ:CSII) was in 12 hedge funds' portfolio at the end of March.
Do Hedge Funds and Insiders Love Cerus Corporation (CERS)?
In today’s marketplace, there are a multitude of indicators market participants can use to watch stocks.
Cytokinetics, Inc. (CYTK): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds' portfolio at the end of March.
XenoPort, Inc. (XNPT): Hedge Funds and Insiders Are Bearish, What Should You Do?
Is XenoPort, Inc. (NASDAQ:XNPT) a healthy stock for your portfolio? Money managers are in a pessimistic mood.
Hedge Funds Are Buying Solta Medical Inc (SLTM)
Is Solta Medical Inc (NASDAQ:SLTM) worth your attention right now? Investors who are in the know are getting more bullish.
Do Hedge Funds and Insiders Love AVEO Pharmaceuticals, Inc. (AVEO)?
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was in 9 hedge funds' portfolio at the end of the first quarter of 2013.
Is Pacific Biosciences of California (PACB) Going to Burn These Hedge Funds?
Pacific Biosciences of California (NASDAQ:PACB) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
Antares Pharma Inc (ATRS): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
In the eyes of most shareholders, hedge funds are perceived as worthless, old financial vehicles of the past.
AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?
In today’s marketplace, there are tons of indicators market participants can use to monitor the equity markets.
Healthways, Inc. (HWAY): Insiders Aren’t Crazy About It
Healthways, Inc. (NASDAQ:HWAY) was in 10 hedge funds' portfolio at the end of March. HWAY shareholders have witnessed a decrease in hedge fund interest recently.
Hedge Funds Are Crazy About Cytokinetics, Inc. (CYTK)
Is Cytokinetics, Inc. (NASDAQ:CYTK) the right pick for your portfolio? Prominent investors are in a bullish mood.
